Found: 65
Select item for more details and to access through your institution.
Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01069-9
- By:
- Publication type:
- Article
Cost comparison of post-remission strategies in younger and older AML patients in France.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00874-y
- By:
- Publication type:
- Article
Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13626-y
- By:
- Publication type:
- Article
Targeting Tyrosine Kinases in Acute Myeloid Leukemia: Why, Who and How?
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 14, p. 3429, doi. 10.3390/ijms20143429
- By:
- Publication type:
- Article
A comparison of toxicity following two different doses of cyclophosphamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patients.
- Published in:
- Bone Marrow Transplantation, 2001, v. 27, n. 8, p. 837, doi. 10.1038/sj.bmt.1702879
- By:
- Publication type:
- Article
Autologous stem cell transplantation in chronic myeloid leukemia: a single center experience.
- Published in:
- Bone Marrow Transplantation, 1999, v. 24, n. 3, p. 265, doi. 10.1038/sj.bmt.1701871
- By:
- Publication type:
- Article
Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience.
- Published in:
- Bone Marrow Transplantation, 1998, v. 22, n. 8, p. 763, doi. 10.1038/sj.bmt.1701435
- By:
- Publication type:
- Article
Induction-related cost of patients with acute myeloid leukaemia in France.
- Published in:
- International Journal of Clinical Pharmacy, 2011, v. 33, n. 2, p. 191, doi. 10.1007/s11096-010-9462-1
- By:
- Publication type:
- Article
The place of interstitial therapy using <sup>192</sup>iridium in the management of carcinoma of the lip.
- Published in:
- Cancer (0008543X), 1979, v. 43, n. 3, p. 1073, doi. 10.1002/1097-0142(197903)43:3<1073::AID-CNCR2820430343>3.0.CO;2-8
- By:
- Publication type:
- Article
VANDA regimen followed by blinatumomab leads to favourable outcome in patients with Philadelphia chromosome‐negative B‐precursor acute lymphoblastic leukaemia in first relapse.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 523, doi. 10.1111/bjh.18218
- By:
- Publication type:
- Article
Chronic myelomonocytic leukaemia followed by blastic plasmacytoid dendritic cell neoplasm.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Outcome after hematopoietic stem cell transplantation in patients with extranodal natural killer/T‐Cell lymphoma, nasal type: A French study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM‐TC).
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. 834, doi. 10.1002/ajh.26200
- By:
- Publication type:
- Article
Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric study.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective study.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 3, p. 759, doi. 10.1007/s00277-024-05623-0
- By:
- Publication type:
- Article
BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Erratum to: BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib.
- Published in:
- 2017
- By:
- Publication type:
- corrected article
Cardiac failure in patients treated with azacitidine, a pyrimidine analogue: Case reports and disproportionality analyses in Vigibase.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 5, p. 991, doi. 10.1111/bcp.14211
- By:
- Publication type:
- Article
Autophagy Targeting and Hematological Mobilization in FLT3-ITD Acute Myeloid Leukemia Decrease Repopulating Capacity and Relapse by Inducing Apoptosis of Committed Leukemic Cells.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 453, doi. 10.3390/cancers14020453
- By:
- Publication type:
- Article
Allogenic Stem Cell Transplantation Abrogates Negative Impact on Outcome of AML Patients with KMT2A Partial Tandem Duplication.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2272, doi. 10.3390/cancers13092272
- By:
- Publication type:
- Article
Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid Leukemia.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 629, doi. 10.3390/cancers13040629
- By:
- Publication type:
- Article
Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2044, doi. 10.3390/cancers12082044
- By:
- Publication type:
- Article
Outcome of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse–Bordeaux DATAML Registry Study.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 773, doi. 10.3390/cancers12040773
- By:
- Publication type:
- Article
Clofarabine Improves Relapse-Free Survival of Acute Myeloid Leukemia in Younger Adults with Micro-Complex Karyotype.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 88, doi. 10.3390/cancers12010088
- By:
- Publication type:
- Article
Conventional chemotherapy for acute myeloid leukemia in older adults: Impact on nutritional, cognitive, and functional status.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 6, p. 859, doi. 10.1111/ejh.13624
- By:
- Publication type:
- Article
Cervical and vaginal cancer associated with pessary use.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.7003
- By:
- Publication type:
- Article
Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 2, p. 1482, doi. 10.1002/cam4.5039
- By:
- Publication type:
- Article
Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score matching analysis.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 18, p. 6336, doi. 10.1002/cam4.4182
- By:
- Publication type:
- Article
Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemia.
- Published in:
- European Journal of Haematology, 2017, v. 98, n. 5, p. 443, doi. 10.1111/ejh.12850
- By:
- Publication type:
- Article
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial).
- Published in:
- 2007
- By:
- Publication type:
- journal article
Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first‐line treatment.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 9, p. 1931, doi. 10.1002/cncr.21418
- By:
- Publication type:
- Article
Acute leukemia during pregnancy: A report on 37 patients and a review of the literature.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 1, p. 110, doi. 10.1002/cncr.21137
- By:
- Publication type:
- Article
Allogeneic SCT for patients with high-risk peripheral T-cell lymphoma in first response.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1484, doi. 10.1038/bmt.2013.86
- By:
- Publication type:
- Article
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. 364, doi. 10.1016/j.clml.2024.01.007
- By:
- Publication type:
- Article
MDS-335: Ivosidenib (IVO) in Patients with IDH1-Mutant Relapsed/Refractory Myelodysplastic Syndrome (R/R MDS): Updated Enrollment for the MDS Sub-Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S346, doi. 10.1016/S2152-2650(21)01805-X
- By:
- Publication type:
- Article
Poster: MDS-335: Ivosidenib (IVO) in Patients with IDH1-Mutant Relapsed/Refractory Myelodysplastic Syndrome (R/R MDS): Updated Enrollment for the MDS Sub-Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S230, doi. 10.1016/S2152-2650(21)01451-8
- By:
- Publication type:
- Article
Antifungal Stewardship in Hematology: Reflection of a Multidisciplinary Group of Experts.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Ivosidenib (AG-120) in Mutant IDH1 Relapsed/Refractory Acute Myeloid Leukemia: Results of a Phase 1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S204, doi. 10.1016/j.clml.2018.07.057
- By:
- Publication type:
- Article
Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician survey.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00712-7
- By:
- Publication type:
- Article
Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Long-term results of a randomized phase 3 trial comparing idarubicin and daunorubicin in younger patients with acute myeloid leukaemia.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 2, p. 440, doi. 10.1038/leu.2013.290
- By:
- Publication type:
- Article
A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial.
- Published in:
- Leukemia (08876924), 2010, v. 24, n. 7, p. 1380, doi. 10.1038/leu.2010.111
- By:
- Publication type:
- Article
Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS study.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 2, p. 350, doi. 10.1038/leu.2008.296
- By:
- Publication type:
- Article
EBV-positive lymphoproliferative disease with medullary, splenic and hepatic infiltration after imatinib mesylate therapy for chronic myeloid leukemia.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Nucleophosmin status may influence the therapeutic decision in de novo acute myeloid leukemia with normal karyotype.
- Published in:
- 2006
- By:
- Publication type:
- Letter
High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia.
- Published in:
- Leukemia (08876924), 2006, v. 20, n. 3, p. 400, doi. 10.1038/sj.leu.2404115
- By:
- Publication type:
- Article